EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
54 hedge funds and large institutions have $61M invested in ESSA Pharma in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $119M → $61M (-$58M)
Holders
54
Holding in Top 10
–
Calls
$80K
Puts
–
Top Buyers
| 1 | +$9.19M | |
| 2 | +$1.62M | |
| 3 | +$940K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$696K |
| 5 |
Two Sigma Investments
New York
|
+$539K |
Top Sellers
| 1 | -$9.17M | |
| 2 | -$6.31M | |
| 3 | -$3.28M | |
| 4 |
Morgan Stanley
New York
|
-$2.85M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.78M |